FMC Corporation 10-Q Summary: Period Ended June 30, 1997
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 1997, and the six-month period ended on that date. FMC Corporation operates through four primary segments: Performance Chemicals, Industrial Chemicals, Machinery and Equipment, and Defense Systems. The financial statements are unaudited but have been reviewed by independent accountants (KPMG Peat Marwick LLP and Ernst & Young LLP for United Defense, L.P.).
Key Financial Metrics
| Metric (in millions) | Q2 1997 | Q2 1996 | 6-Mo 1997 | 6-Mo 1996 |
|---|---|---|---|---|
| Total Revenue | $1,478.1 | $1,266.8 | $2,775.8 | $2,399.9 |
| Net Income | $72.8 | $56.3 | $112.7 | $111.5 |
| EPS (Diluted) | $1.90 | $1.48 | $2.95 | $2.93 |
| Operating Cash Flow (6-Mo) | $350.7 (vs. $(134.5) in 1996) | |||
| Total Debt | $1.7 billion (down from $1.8 billion) | |||
| Cash & Equivalents | $105.6 million (up from $74.8 million) | |||
| Order Backlog | $2.5 billion |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 16% in Q2 and 17% for the six months ended June 30, 1997, compared to the prior year. Growth was driven by the Machinery and Equipment segment (36% increase in Q2) and Defense Systems (16% increase in Q2).
- Profitability: Net income rose 29% in Q2 1997 compared to Q2 1996. However, for the six-month period, net income remained relatively flat ($112.7M vs. $111.5M) due to higher interest expenses and manufacturing start-up costs.
- Segment Performance:
- Machinery & Equipment: Profits surged 70% in Q2, aided by the acquisition of Frigoscandia and strong petroleum equipment sales.
- Performance Chemicals: Sales grew 8%, but earnings declined due to start-up costs at the new sulfentrazone plant and price weakness in termiticide markets.
- Industrial Chemicals: Earnings increased 27% in Q2 despite flat sales, driven by improved operating performance in phosphorus and alkali products.
- Debt & Liquidity: Total borrowings decreased by approximately $100 million to $1.7 billion. Commercial paper borrowings were reduced by $271 million, partially offset by new advances under a five-year revolving credit agreement. Cash provided by operating activities improved significantly to $350.7 million for the six-month period, compared to a negative $134.5 million in the prior year.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects capital spending of $150 million to $200 million for the remainder of 1997, excluding potential acquisitions.
- Project Status:
- Sulfentrazone Plant: Production issues are being resolved; increased production is expected in 1998.
- Lithium Plant (Argentina): Construction difficulties have delayed start-up; initial production is now expected in Q4 1997. Market prices for lithium carbonate remain depressed due to foreign competition.
- Environmental Contingencies: FMC has reserved $247 million for environmental obligations. Management estimates reasonably possible losses could exceed reserves by up to $150 million. Specific concerns include the Eastern Michaud Flats Superfund site (reserve approx. $72 million) and potential civil enforcement actions regarding the Pocatello, Idaho facility.
- Discontinued Operations: The sale of FMC Gold Company is subject to limited recourse regarding installment payments due July 31, 1997. Management does not expect significant recourse based on current stock prices.
Investor Verification Checklist
- Verify the timeline and cost implications of the delayed lithium carbonate plant start-up in Argentina.
- Monitor the resolution of production issues at the sulfentrazone plant and its impact on 1998 earnings.
- Review the status of the EPA investigation at the Pocatello, Idaho facility and potential civil penalties.
- Assess the impact of foreign currency fluctuations (specifically the Spanish peseta) on the Industrial Chemicals segment.
- Confirm the finalization of the FMC Gold Company sale and any potential recourse liabilities.